相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience
Leyla Bojanini et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas
Francine M. Foss et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Hepatosplenic T-cell lymphoma: a rare but challenging entity
Barbara Pro et al.
BLOOD (2020)
A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation
Noriko Iwaki et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2020)
Gamma-delta hepato-splenic T-cell lymphoma: a pathological illustration
Saniya Dhawan et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Hepatosplenic - T-Cell Lymphoma: Who Is on Your Speed Dial?
Mridula Krishnan et al.
JOURNAL OF ONCOLOGY PRACTICE (2019)
A rare case of hepatosplenic γδ T-cell lymphoma expressing CD19 with ring chromosome 7 and trisomy 8
Hemani Jain et al.
CANCER GENETICS (2018)
Successful second allogeneic stem-cell transplantation from the same sibling donor for a patient with recurrent hepatosplenic gamma-delta (gamma/delta) T-cell lymphoma A case report
Hui Pan et al.
MEDICINE (2018)
The Genetic Basis of Hepatosplenic T-cell Lymphoma
Matthew McKinney et al.
CANCER DISCOVERY (2017)
Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review
Mariko Yabe et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2017)
Challenges and new prospects in hepatosplenic γδT-cell lymphoma
Marco Calvaruso et al.
LEUKEMIA & LYMPHOMA (2014)
Hepatosplenic γδ T-cell Lymphoma: An Overview
Koppany Visnyei et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Intensive Induction Chemotherapy Followed by Early High-Dose Therapy and Hematopoietic Stem Cell Transplantation Results in Improved Outcome for Patients with Hepatosplenic T-Cell Lymphoma: A Single Institution Experience
Martin H. Voss et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2013)
Intensified alemtuzumab-CHOP therapy for peripheral T-cell lymphoma
H. C. Kluin-Nelemans et al.
ANNALS OF ONCOLOGY (2011)
Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment
G. S. Falchook et al.
ANNALS OF ONCOLOGY (2009)
Heterogeneous CD52 expression among hematologic neoplasms: Implications for the use of alemtuzumab (CAMPATH-1H)
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2006)
Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome:: report on a series of 21 patients
K Belhadj et al.
BLOOD (2003)
Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990
E Weidmann
LEUKEMIA (2000)
分享论文
